Novartis Seeks to Acquire CellforCure in France, an Industrial Info Market Brief
Novartis Seeks to Acquire CellforCure in France, an Industrial Info Market Brief
Attachment: Novartis
Pharmaceuticals company Novartis has made an offer to acquire French contract development and manufacturing organization CellforCure, which specializes in cell and gene therapies. Novartis would take ownership of CellforCure's site in Ulis, France. Novartis has 35 operational sites across Europe. See map below.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
